Editas Medicine EDIT
NASDAQ EDIT
$2.59 +0.08 (+3.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Non-Current Debt (2024 - 2025)

Updated

Editas Medicine (EDIT) posted Non-Current Debt of $53.61 million for Q4 2025, up 2.2% from $52.43 million a year earlier but down 0.9% from the prior quarter.

Analysis

Editas Medicine (EDIT) Non-Current Debt (2024 - 2025) Analysis & Trends

Since Q4 2024, Editas Medicine has reported Non-Current Debt for 5 quarters.

  • In prior years, Editas Medicine's Non-Current Debt was $52.43 million in FY2024.
  • Quarterly Non-Current Debt has run from a low of $49.58 million in Q1 2025 to a high of $54.07 million in Q3 2025 over five years.
  • According to Business Quant data, Non-Current Debt for the three prior quarters was $54.07 million (Q3 2025), $51.67 million (Q2 2025) and $49.58 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Editas Medicine 234.09 Mn -477.66 Mn - 53.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 53.61 Mn
Sep 30, 2025 54.07 Mn
Jun 30, 2025 51.67 Mn
Mar 31, 2025 49.58 Mn
Dec 31, 2024 52.43 Mn
API Access

Editas Medicine Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=EDIT&period=max&api_key=YOUR_API_KEY